Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heejun Kang
Observed name:
Hee-Jun Kang
Institutions:
The Catholic University of Korea Eunpyeong St. Mary's Hospital,
Catholic University of Korea
Observed institutions:
The Catholic University of Korea Eunpyeong St. Mary's Hospital,
Catholic University of Korea
ORCID:
0000-0003-2202-2705
Observed ORCID:
0000-0003-2202-2705
OpenAlex ID:
A5040870429
Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy
2022
·
Sang-Gon Moon
, Chul-Hyun Lim
, et al.
·
Journal of Clinical Medicine
·
11
PDF
Usefulness of the Kyoto Classification Score for Prediction of Current Helicobacter pylori Infection
2022
·
Heejun Kang
, Chul-Hyun Lim
, et al.
·
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
·
3
PDF
Eradication of Helicobacter pylori Infection Using 7-day PCR-based Tailored Therapy
2023
·
Youngwoo Kim
, Heejun Kang
, et al.
·
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
·
2
PDF
Show more works
View as search
Works count:
3
Citation count:
16
H-index:
2
I10-index:
1
Year
Topic
Type